Twist Bioscience Corp (TWST) Stock Price Today
Aura AI Summary
Key Stats
- $6.29BMarket Cap
- -Volume
- HealthSector
- $102.8852W High
- $24.1652W Low
- -Typical Hold Time
- $6.22BEnterprise Value
- -Div Yield
- -Trading Activity
Track Twist Bioscience Corp (TWST) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Twist Bioscience Corp has traded between a low of $24.16 and a high of $102.88, highlighting its annual price range. Buy and sell Twist Bioscience Corp shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Most Recent News
Global advanced carbon materials market forecasted to grow through 2037 driven by EVs, renewables, aerospace, and AI.
A new market report forecasts significant growth in the global advanced carbon materials sector through 2037, driven by rising demand in electric vehicles, renewable energy, aerospace, defense, and AI infrastructure. The report covers 16 material cat...

Court reveals Abacus misled investors with flawed life expectancy data in life settlements case
A U.S. court unsealed documents showing Abacus Global Management relied on inaccurate, short life expectancy estimates from Lapetus Solutions, misleading investors about the value of life settlement policies. The evidence reveals Lapetus had an actua...

PROCEPT BioRobotics faces securities fraud lawsuit ahead of earnings report with expected loss.
PROCEPT BioRobotics is confronting a securities fraud class action lawsuit alleging it artificially boosted sales by pulling future sales into current quarters. This legal issue caused an 18% drop in its stock price. The company is set to report earn...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.